TP53 and neoplasm: The efficient mitochondria-targeted antioxidant SkQ1 [17] suppressed a spontaneous tumor (predominantly lymphomas) development in homozygous p53 knockout mice and inhibited the growth of human colon carcinoma HCT116/p53−/− xenografts in athymic mice [16].